Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT (MULTIPRAT)

This study is ongoing, but not recruiting participants.
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Carlos Ramos, Baylor College of Medicine Identifier:
First received: February 9, 2009
Last updated: July 20, 2016
Last verified: July 2016